BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 19 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $9,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2016 | $9,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | +12.5% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2015 | $10,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2015 | $12,000 | +9.1% | 2,000 | 0.0% | 0.00% | – |
| Q1 2015 | $11,000 | +37.5% | 2,000 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | +14.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $7,000 | +16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | -14.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2014 | $7,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2013 | $7,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2013 | $7,000 | +16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 22,379,000 | $95,967,000 | 0.78% |
| Steward Partners Investment Advisory, LLC | 5,000 | $21,000 | 0.00% |
| UBS Group AG | 21,000 | $90,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,000 | $9,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $4,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 1,000 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 8,000 | $34,000 | 0.00% |